Silver Book Fact

Spending $1,000 per year on anticoagulants can save $100,000 in hospital costs for care of a person disabled by a stroke.

Giorgianni, Salvatore J., John Grana, and Lisa Scipioni. Global Impact of Innovations on Chronic Disease in the Genomics Era. The Pfizer Journal. 01-Nov-2001; 11

Reference

Title
Global Impact of Innovations on Chronic Disease in the Genomics Era
Publication
The Pfizer Journal
Publisher
Pfizer Inc
Publication Date
01-Nov-2001
Authors
Giorgianni, Salvatore J., John Grana, and Lisa Scipioni

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Cardiovascular disease death rates
    Cardiovascular disease accounts for nearly 801,000 deaths in the US, or about 1 of every 3 deaths in the US.  
  • A blood thinning drug was found to reduce the risk of heart attack, stroke, and cardiovascular disease by 20% in patients with acute coronary syndrome when given in addition to…  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.